Donald VanDevanter Ph.D.

Dr. VanDevanter has a BS in Chemistry and Biology, an MS in Toxicology, and a PhD in Medicinal Chemistry. He has worked in the CF field for 17 years in drug discovery, clinical development, and retrospective data analyses, and is an author on more than 65 peer-reviewed publications, 5 book chapters, and 2 issued patents.